Cargando…
Successful Outcome of Programmed Death 1 Blockade Plus GemOx for Epstein-Barr Virus-Associated Primary Nodal T/NK Cell Lymphoma: A Case Report
Epstein-Barr virus (EBV)-associated lymph nodal T/NK cell lymphoma (nodal TNKL) is a rare and aggressive malignancy with an extremely poor prognosis. Although treatments of extranodal NK/T cell lymphoma are frequently reported, the characteristics and pathogenesis of EBV-associated nodal TNKL are di...
Autores principales: | Xia, Liang, Zhang, Han-Shuo, Bao, Jing, Zhao, Yu-Chen, Xia, Hai-Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285057/ https://www.ncbi.nlm.nih.gov/pubmed/34277451 http://dx.doi.org/10.3389/fonc.2021.706865 |
Ejemplares similares
-
Gallbladder cancer with EGFR mutation and its response to GemOx with erlotinib: a case report and review of literature
por: Soni, Kishan, et al.
Publicado: (2020) -
Real-World Evidence on Palliative Gemcitabine and Oxaliplatin (GemOx) Combination Chemotherapy in Advanced Biliary Tract Cancer
por: Lagenfelt, Hanna, et al.
Publicado: (2021) -
Outcomes of patients treated with SVILE vs. P-GemOx for extranodal natural killer/T-cell lymphoma, nasal type: a prospective, randomized controlled study
por: Wei, Liqiang, et al.
Publicado: (2020) -
Nodal Epstein-Barr virus-positive T-cell/NK-cell lymphoma associated with immunodeficiency: a rare condition looking for recognition
por: Ferreira, Cristiane Rúbia, et al.
Publicado: (2014) -
Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes
por: Ng, Siok-Bian, et al.
Publicado: (2018)